EG23929A - Isoxazolines derivatives and their use as antidepressants - Google Patents

Isoxazolines derivatives and their use as antidepressants

Info

Publication number
EG23929A
EG23929A EG20020197A EG20020197A EG23929A EG 23929 A EG23929 A EG 23929A EG 20020197 A EG20020197 A EG 20020197A EG 20020197 A EG20020197 A EG 20020197A EG 23929 A EG23929 A EG 23929A
Authority
EG
Egypt
Prior art keywords
antidepressants
isoxazolines
derivatives
isoxazolines derivatives
Prior art date
Application number
EG20020197A
Other languages
English (en)
Inventor
Jose I Andres-Gil
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of EG23929A publication Critical patent/EG23929A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
EG20020197A 2001-02-21 2002-02-19 Isoxazolines derivatives and their use as antidepressants EG23929A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01200611 2001-02-21
EP01201264 2001-04-05

Publications (1)

Publication Number Publication Date
EG23929A true EG23929A (en) 2008-01-14

Family

ID=26076836

Family Applications (1)

Application Number Title Priority Date Filing Date
EG20020197A EG23929A (en) 2001-02-21 2002-02-19 Isoxazolines derivatives and their use as antidepressants

Country Status (32)

Country Link
US (1) US7169786B2 (de)
EP (1) EP1368358B1 (de)
JP (1) JP3953424B2 (de)
KR (1) KR100848898B1 (de)
CN (1) CN100400540C (de)
AR (1) AR035685A1 (de)
AT (1) ATE337322T1 (de)
AU (1) AU2002244717B2 (de)
BG (1) BG107984A (de)
BR (1) BR0207433A (de)
CA (1) CA2437505C (de)
CY (1) CY1106448T1 (de)
CZ (1) CZ20032515A3 (de)
DE (1) DE60214138T2 (de)
DK (1) DK1368358T3 (de)
EA (1) EA006747B1 (de)
EE (1) EE200300398A (de)
EG (1) EG23929A (de)
ES (1) ES2271230T3 (de)
HR (1) HRP20030647A2 (de)
HU (1) HUP0303270A3 (de)
IL (2) IL157470A0 (de)
MX (1) MXPA03007432A (de)
MY (1) MY137836A (de)
NO (1) NO20033700L (de)
NZ (1) NZ526741A (de)
PL (1) PL208593B1 (de)
PT (1) PT1368358E (de)
SI (1) SI1368358T1 (de)
SK (1) SK11612003A3 (de)
TW (1) TWI257392B (de)
WO (1) WO2002066484A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0203299D0 (en) * 2002-02-12 2002-03-27 Glaxo Group Ltd Novel compounds
NZ536109A (en) * 2002-04-02 2006-06-30 Janssen Pharmaceutica Nv Substituted amino isoxazoline derivatives and their use as anti-depressants
AR040967A1 (es) * 2002-08-12 2005-04-27 Janssen Pharmaceutica Nv Derivados de isoxazolina triciclicos c- sustituidos y su uso como anti- depresivos
ATE456568T1 (de) * 2002-08-15 2010-02-15 Janssen Pharmaceutica Nv Kondensierte heterocyclische isoxazolinderivate und deren verwendung als antidepressiva
ATE387455T1 (de) * 2002-08-21 2008-03-15 Janssen Pharmaceutica Nv C6- und c9-substituierte chromeno(4,3- c)isoxazoline und ihre verwendung als anti- depressiva
BRPI0408136A (pt) * 2003-03-07 2006-03-01 Astellas Pharma Inc derivados heterocìclicos contendo nitrogênio tendo estirila 2,6-dissubstituìda
ES2319539T3 (es) * 2003-09-17 2009-05-08 Janssen Pharmaceutica Nv Compuestos heterociclicos condensados como moduladores del receptor de serotonina.
EP1944306A1 (de) * 2003-09-17 2008-07-16 Janssen Pharmaceutica, N.V. Fusionierte heterocyclische Verbindungen
JP2008521771A (ja) * 2004-11-26 2008-06-26 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 改良された抗精神病活性および抗不安症活性を有するイソキサゾリン−インドール誘導体
WO2008112483A2 (en) 2007-03-09 2008-09-18 Sanofi-Aventis Substituted dihydro and tetrahydro oxazolopyrimidinones, preparation and use thereof
WO2008154442A1 (en) * 2007-06-08 2008-12-18 Helicon Therapeutics, Inc. Therapeutic pyrazoloquinoline urea derivatives
JP2011507835A (ja) 2007-12-21 2011-03-10 アンドレイ・アレクサンドロビッチ・イワシェンコ α−アドレナリン受容体、ドーパミン、ヒスタミン、イミダゾリン及びセロトニン受容体のリガンド並びにその使用
AR078171A1 (es) 2009-09-15 2011-10-19 Sanofi Aventis Dihidrobenzocicloalquiloximetil-oxazolopirimidinonas sustituidas, preparacion y uso de las mismas

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2055011T3 (es) * 1988-09-19 1994-08-16 Akzo Nv Un procedimiento para la preparacion de derivados de tetrahidronaftaleno e indano.
US5880121A (en) * 1996-01-05 1999-03-09 Hoechst Marion Roussel Inc. 4,5-dihydronaphth (1,2-c) isoxazoles and derivatives thereof
CN1082963C (zh) * 1996-04-12 2002-04-17 詹森药业有限公司 异噁唑烷衍生物
HUP9602763A3 (en) * 1996-10-09 1999-05-28 Egyt Gyogyszervegyeszeti Gyar 3-phenyl isoxazole derivatives, process for producing them and pharmaceutical compositions containing the same
CA2346396C (en) * 1998-10-09 2009-04-28 Janssen Pharmaceutica N.V. 4,5-dihydro-isoxazole derivatives and their pharmaceutical use

Also Published As

Publication number Publication date
CY1106448T1 (el) 2011-10-12
NZ526741A (en) 2004-04-30
SK11612003A3 (sk) 2004-04-06
IL157470A (en) 2008-07-08
PL208593B1 (pl) 2011-05-31
HK1065537A1 (zh) 2005-02-25
DK1368358T3 (da) 2007-01-02
ES2271230T3 (es) 2007-04-16
EE200300398A (et) 2003-12-15
CA2437505C (en) 2010-02-09
JP3953424B2 (ja) 2007-08-08
SI1368358T1 (sl) 2007-02-28
NO20033700D0 (no) 2003-08-20
PL363264A1 (en) 2004-11-15
HUP0303270A2 (hu) 2004-01-28
DE60214138T2 (de) 2007-03-29
EA200300915A1 (ru) 2004-06-24
EP1368358A1 (de) 2003-12-10
US7169786B2 (en) 2007-01-30
BR0207433A (pt) 2004-06-01
ATE337322T1 (de) 2006-09-15
BG107984A (bg) 2004-09-30
HRP20030647A2 (en) 2005-06-30
DE60214138D1 (de) 2006-10-05
EP1368358B1 (de) 2006-08-23
HUP0303270A3 (en) 2007-03-28
JP2004518748A (ja) 2004-06-24
CZ20032515A3 (cs) 2003-12-17
AR035685A1 (es) 2004-06-23
CA2437505A1 (en) 2002-08-29
US20040122037A1 (en) 2004-06-24
CN100400540C (zh) 2008-07-09
MXPA03007432A (es) 2003-11-18
WO2002066484A1 (en) 2002-08-29
CN1492871A (zh) 2004-04-28
KR20030076590A (ko) 2003-09-26
TWI257392B (en) 2006-07-01
AU2002244717B2 (en) 2007-07-19
EA006747B1 (ru) 2006-04-28
KR100848898B1 (ko) 2008-07-29
NO20033700L (no) 2003-10-21
IL157470A0 (en) 2004-03-28
PT1368358E (pt) 2007-01-31
MY137836A (en) 2009-03-31

Similar Documents

Publication Publication Date Title
IL162266A (en) Substituted 2-thio-3,5-dicyano-4- phenyl-6-aminopyridines and the use of the same
PT1757606E (pt) Utilização de derivados de xantina como produto farmacêutico, bem como seu processo de preparação
EP1367060A4 (de) Glukopyranosyloxybenzylbenzolderivate und deren medizinische verwendung
EP1364957A4 (de) Glykopyranosyloxypyrazolderivate und deren medizinische verwendung
PL375764A1 (en) Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof
EP1364958A4 (de) Glykopyranosyloxypyrazolderivate und deren medizinische verwendung
ZA200204020B (en) Use of anti-CTLA-4-antibodies.
HUP0300268A3 (en) Herbicidal benzoylpyrazole derivatives, compositions containing the same and their use
IL159275A0 (en) Phenylsulfonyl-1, 3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use
DE60208622D1 (de) Siliciumoxidpulver und dessen Herstellung
HUP0402489A3 (en) 5-sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine
IL156161A0 (en) Substituted 2-anilino-benzimidazoles and the use thereof as nhe-inhibitors
IL155520A0 (en) Benzoxazinone derivatives, their preparation and use
EG23929A (en) Isoxazolines derivatives and their use as antidepressants
IL166821A0 (en) Novel 1,4-diazabicycloalkane derivatives their preparation and use
HUP0401092A3 (en) 5-halogen-6-phenyl-7-fluoralkylamino-triazolopyrimidines as fungicides, preparation and use thereof
ZA200309513B (en) Novel heterocyclic derivatives and medicinal use thereof.
IL158056A0 (en) Chemical derivatives and their use as anti-telomerase agent
MXPA03001826A (es) Derivados de arilpiperazina.
SI1532141T1 (sl) 2-pirolidin-2-il-(1,3,4)-oksadiazolni derivati in njihova uporaba kot antidepresivi
HUP0600238A3 (en) Benzothiazole- and benzoxazole-4,7-dione derivatives and their use
PL1786759T3 (pl) Nowe pochodne 3,5-seko-4-norcholestanowe i ich zastosowanie
EP1421101A4 (de) P-glycoproteine und deren verwendungen
IL156794A0 (en) Chemical derivatives and their use as anti-telomerase agent
GB0200843D0 (en) Benzodioxinopyrroles their preparation and use